| Toggle Summary
|
Minerva Neurosciences to Host First Quarter 2015 Financial Results Webcast and Conference Call
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences Reports First Quarter 2015 Financial Results and Other Key Business Updates
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences Announces Appointment of Dr. Fouzia Laghrissi-Thode to Its Board of Directors
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences to Present at Upcoming Investor Conferences in June
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences Provides Update on MIN-202, Selective Orexin-2 Receptor Antagonist
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences to Report Second Quarter 2015 Financial Results and Host Conference Call on August 5, 2015
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences Reports Second Quarter 2015 Financial Results and Business Updates
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences to Present at Baird 2015 Healthcare Conference on September 9, 2015
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences Provides Update on Clinical Development Program With MIN-202, Selective Orexin-2 Receptor Antagonist
Patient Recruitment Ongoing in Trials in Insomnia Disorder and Adjunctive Major Depressive Disorder
|
View HTML
|
| Toggle Summary
|
Minerva Neurosciences to Report Third Quarter 2015 Financial Results and Host Conference Call on November 5, 2015
|
View HTML
|
